The present invention generally relates to the fields of genetic
engineering and antibody production. In particular, it relates to the
generation of genetically modified vertebrate precursor lymphocytes that
have the potential to differentiate into more mature lymphoid lineage
cells, and to the use thereof for the production of any heterologous
antibody or binding protein.